CLINUVEL (ASX:CUV) Renews Share Buy-Back Program
CLINUVEL (ASX:CUV) renews its share buy-back program for up to 1.5 million shares over the next 12 months.
CLINUVEL Pharmaceuticals Limited
CLINUVEL (ASX:CUV) renews its share buy-back program for up to 1.5 million shares over the next 12 months.
CLINUVEL (ASX:CUV) reports positive preliminary results from its latest stroke treatment study, highlighting high patient improvement rates.